A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
Clinical trial NCT04427501 · COMPLETED
Trial details
- NCT number
- NCT04427501
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2023-02-21
- Enrollment
- 3307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.